Zura Bio ZURA 深 沪
已收盘 07-02 16:00:00 美东时间
5.17
+0.165
+3.30%
华盛通- 最 高5.395
- 今 开5.09
- 成交量 90.83万股
- 最 低 4.94
- 昨 收 5.005
- 总市值 49.11万
- 52周最高 7.44
- 市盈率 静 --
- 换手率 0.96%
- 52周最低 1.26
- 委 比 23.95%
- 总股本 9.50万
- 历史最高 37.55
- 量 比 0.25
- 振 幅 9.09%
- 历史最低 0.97
- 每 手 1
- 风险率 1.65%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅392.61%！Chardan Capital维持EyePoint"买入"评级，上调目标价至65美元
今日重点评级关注：Chardan Capital：维持EyePoint"买入"评级，目标价从29美元升至65美元；康托·菲茨杰拉德：维持Hyperliquid Strategies"超配"评级，目标价从8美元升至18.4美元
07-02 18:41
Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price Target
Wedbush analyst Martin Fan reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and maintains $15 price target.
07-01 21:56
Zura Bio大涨44% 大额资金离场
祖拉生物（ZURA.O）近期股价累计上涨44.59%，当前处于高波动状态，机构与散户资金流向呈现明显分化。 核心关键数据： 基本面：资产市值比为-21.66...
06-30 10:18
Zura Bio Completes Enrollment In Phase 2 TibuSHIELD Trial of Tibulizumab in Adults With HS
Tibulizumab is the first and only bispecific antibody targeting both BAFF and IL-17 in clinical development TibuSHIELD has completed enrollment, exceeding enrollment target with 247 participants randomized in HS; topline data expected Q4 2026 TibuSURE has exceeded the 80 participant enrollment targe...
06-29 19:32
Zura Bio：分析师给出买入评级 聪明资金却在抛售
祖拉生物（ZURA.O）当前呈现多空博弈格局，生物科技板块整体受大额资本布局支撑，但个股自身技术面方向不明，波动将持续，暂无单边上涨基础。 核心行业动态：B...
06-29 10:18
Zura Bio grants Chief Business Officer option for 600,000 shares at $4.8###
Zura Bio grants Chief Business Officer option for 600,000 shares at $4.8### Zura Bio granted Chief Business Officer Muzammil Mustufa an inducement stock option for 600,000 Class A ordinary shares, with grant date May 13, 2026. Exercise price set at USD 4.8 per share, matching closing price on May 13
05-14 19:30
Zura Bio Q1 EPS $(0.22) Misses $(0.18) Estimate
Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by 22.22 percent. This is a 15.79 percent decrease over losses of $(0.19) per share from the
05-07 20:56
AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed in lower-than-planned orbit. Other stocks decline in pre-market trading.
04-20 20:02
美股大行评级 | 小摩、瑞穗等下调阿里目标价最低至164美元；达登饭店、联邦快递、林肯教育服务、Planet Labs等获多家大行上调目标价
今日重点评级关注：瑞穗：维持RELMADA THERAPEUTICS"跑赢大市"评级，目标价从10美元升至19美元；奥本海默：维持Pelthos Therapeutics"跑赢大市"评级，目标价从60美元升至62美元
03-23 13:53
Oppenheimer Maintains Outperform on Zura Bio, Lowers Price Target to $15
Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $16 to $15.
03-20 23:02
